CC BY-NC-ND 4.0 · Journal of Cardiac Critical Care TSS 2020; 04(01): 47-50
DOI: 10.1055/s-0040-1712739
Point of Technique

Coagulopathy in COVID-19: Connecting the Dots Together

Ajay Gandhi
1   Clinical Affairs, Instrumentation Laboratory India Private Limited, New Delhi, India
Klaus Görlinger
2   Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, Essen, Germany
3   Medical Director, Tem Innovations GmbH, Munich, Germany
› Author Affiliations


Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus has spread quickly and become a public health emergency of global concern. Originating in the Wuhan district of China, which has reportedly been declared free of it now, the rest of the world continues to struggle with its severity and spread. While a lot of scientific publications and clinical data are available, newer clinical investigations and experiences continue to evolve, thereby depicting the dynamic nature of the disease and the knowledge around it. Researchers and clinical professionals continue to collect scientific information, clinical data, and evidence to help build a knowledge pool and guidance for the health care professionals to manage those affected with this pandemic disease. As significant and new data emerge, a lot of already available information gets confirmed and updated, while some of it also getting rejected or disapproved. In this article, we aim to put together the scientific and clinical information that is proven so far and the areas where more data or evidence is needed before a clear understanding can be achieved and guidance can be developed.

Publication History

Article published online:
19 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India